RECRUITING

Quantitative Cardiac Parametric Mapping

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.

Official Title

Novel Magnetic Resonance Imaging Techniques for Quantitative Cardiac Parametric Mapping

Quick Facts

Study Start:2014-06-20
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02855554

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subject must be 18-90 years of age.
  2. * Subject must be previously diagnosed with or suspected to have one of the following conditions.
  3. * Myocardial ischemia or infarction (group 1)
  4. * Hypertrophic cardiomyopathy (group 2)
  5. * Infiltrative cardiomyopathy (group 3)
  6. * Myocarditis (group 4)
  7. * Subject must have been referred for a clinically indicated CMR.
  1. * Subject has any implanted device or condition in which an MR scan would be contraindicated.
  2. * Subject has an acute psychiatric disorder or is cognitively impaired.
  3. * Subject is using or is dependent on substances of abuse.
  4. * Subject is unwilling to comply with the requirements of the protocol.
  5. * Subject has previously entered this study.
  6. * Subject has an allergy against MRI contrast agents.
  7. * Subject is in acute unstable condition.

Contacts and Locations

Study Contact

Mark Ghent, BA
CONTACT
843-876-7148
ghent@musc.edu
Jacob Rowe, BA
CONTACT
843-876-4922
roweja@musc.edu

Principal Investigator

Joseph U. Schoepf, MD
PRINCIPAL_INVESTIGATOR
Medical University of South Carolina

Study Locations (Sites)

Medical University of South Carolina
Charleston, South Carolina, 29425
United States

Collaborators and Investigators

Sponsor: Medical University of South Carolina

  • Joseph U. Schoepf, MD, PRINCIPAL_INVESTIGATOR, Medical University of South Carolina

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-06-20
Study Completion Date2025-12

Study Record Updates

Study Start Date2014-06-20
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • myocardial tissue characterization

Additional Relevant MeSH Terms

  • Cardiomyopathy, Myocarditis, Ischemic Heart Disease